Marseille-Kliniken AG

EANS-Adhoc: - 2010/2011 annual financial statements show improved earnings figures - Issue of a bond for EUR 15 million on 31 October 2011

--------------------------------------------------------------------------------
  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
Issue of a bond

27.10.2011

Berlin, 27 October 2011. - Marseille-Kliniken AG (Prime Standard, ISIN DE
0007783003, MKA) has presented its annual report for the 2010/2011 financial
year (balance sheet date 30 June 2011). Revenues came out to EUR 190.0 million
and, due to the change in the scope of consolidation, fell short of the previous
year's figure of EUR 240.7 million. EBIT increased by 33.1 per cent to EUR 5.7
million. Shareholder's equity on the balance sheet rose by 37.1 per cent to EUR
34.2 million as a result of the capital increases. This equals an equity ratio
of 17.1 per cent (previous year: 12.6 per cent). Financial debt was cut back by
8.5 per cent to EUR 57.1 million. The company expects consolidated EBIT in the
current year well in excess of the previous year's level.

The Management Board, with the approval of the Supervisory Board, has resolved
to issue partial bearer bonds with a total nominal amount of up to EUR
15,000,000. The partial bonds have a term of two years as well as an interest
rate of 9.5 per cent in the first year and 12.5 per cent in the second year.

Marseille-Kliniken AG intends to use the net proceeds from the issue to
refinance its existing liabilities. The partial bonds are to be introduced to
the Open Market of the Frankfurt Stock Exchange. They will be issued on 31
October 2011 and placed with institutional investors in Germany and Europe in
the scope of a private placement.

No offer: This release is neither an offer nor a solicitation for an offer to
purchase securities. The securities of Marseille-Kliniken AG described here are
not offered for sale in the United States and are not registered in accordance
with the U.S. Securities Act.

End, ad hoc release


Further inquiry note:
Hildegard Filz
Marseille-Kliniken AG
Sportallee 1
22335 Hamburg
Germany
Tel.: +49-(0)40 / 51459-0
www.marseille-kliniken.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:     info@marseille-kliniken.de
WWW:      http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
             Stuttgart, Düsseldorf, regulated dealing: Hamburg 
language:   English
 



Weitere Meldungen: Marseille-Kliniken AG

Das könnte Sie auch interessieren: